Testosterone Topical Gel, 1.62% Metered Pump + AndroGel (testosterone gel) 1.62% Metered-Dose Pump
Phase 3Completed 1 views this week 0 watching💤 Quiet
Interest: 37/100
37
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Primary Hypogonadism
Conditions
Primary Hypogonadism, Hypogonadotropic Hypogonadism
Trial Timeline
Mar 1, 2014 → May 1, 2014
NCT ID
NCT02110368About Testosterone Topical Gel, 1.62% Metered Pump + AndroGel (testosterone gel) 1.62% Metered-Dose Pump
Testosterone Topical Gel, 1.62% Metered Pump + AndroGel (testosterone gel) 1.62% Metered-Dose Pump is a phase 3 stage product being developed by Amneal Pharmaceuticals for Primary Hypogonadism. The current trial status is completed. This product is registered under clinical trial identifier NCT02110368. Target conditions include Primary Hypogonadism, Hypogonadotropic Hypogonadism.
What happened to similar drugs?
20 of 20 similar drugs in Primary Hypogonadism were approved
Approved (20) Terminated (6) Active (0)
Hype Score Breakdown
Clinical
17
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02110368 | Phase 3 | Completed |
Competing Products
20 competing products in Primary Hypogonadism